• National Imaging Facility
  • NIF Nodes
  • Organisational Structure
    • Governing Board
    • Operations Committee
      • Fact Sheets
• Access
  • Facilities & Instrumentation: Access Pricing
    • Access Criteria
    • Access Application
    • Subsidised Access Program
      • Subsidised Access Application
• Contact Information
  • Office Holders
  • Node Directors
  • Facility Fellows
  • Informatics Officers
  • Platform Technology Officers
• Example Projects
• Publications
• NIF Submission to 2011 Strategic Roadmap
• Acknowledge NIF
• NIF Sponsored Workshop - Skeptical Neuroimaging Analysis Workshop
• National Imaging Facility: User Survey
• National Imaging Facility: Privacy Statement
• NIF Quarterly Newsletter

The University of Sydney/ANSTO Node

Tracer Based Molecular Imaging & Radioligand Development

Node Director:

• Prof Richard Banati 

Operational participants:

• Brain & Mind Research Institute at the University of Sydney
• ANSTO LifeSciences

Scope and function:

• The University of Sydney/ANSTO node is a shared facility that provides the research community with access to cyclotron based radioisotopes (¹⁸F and ¹¹C) and radiochemistry/pre-clinical imaging technologies on a collaborative basis. The NCRIS-funded research cyclotron and associated radiochemistry hotcells are housed in the ANSTO Camperdown facility adjacent to the Brain and Mind Research Institute (BMRI) and supported by the expertise of ANSTO cyclotron engineers and radiochemists. The pre-clinical imaging platform is located in the purpose built laboratories of the BMRI and jointly operated by ANSTO and BMRI teams with long standing expertise in molecular imaging. A Platform Technology Officer funded by NCRIS supports the reserach user community through assistance with project design, project management, staff/student training and, where appropriate, data analysis.

• The cyclotron and radiochemistry facility includes an 18 MeV dedicated research cyclotron, several hotcells and radiochemistry synthesis untis (RSCU) for ¹⁸F and ¹¹C automated radiosynthesis of biomarkers. The pre-clinical imaging platform includes PET, PET/CT and PET/SPECT/CT scanners, autoradiography, radiometabolite analysis and tissue counting facilities. The University of Sydney/ANSTO node makes 70% of the capacity of 4 hotcells and 2 RCSUs and 10% of the pre-clinical imaging capacity (all modalities) available to the national capability.  The BMRI has also committed 10% access to the 3T clinical research MRI system for imaging and spectroscopy. 

Return to Home Page

NIF Founding Nodes

Large Animal Research
& Imaging Facility